Clinical & Pharma

A new generation of pharmaceutical trade agreements is fundamentally reshaping the landscape of global healthcare, moving beyond abstract economic frameworks to become practical, patient-centric instruments designed to directly enhance the accessibility, affordability, and predictability of

The silent, invisible spread of a novel virus across continents has become a defining challenge of our time, demanding a response that moves faster than the pathogen itself. In this high-stakes race, traditional epidemiological methods of contact tracing and symptom monitoring, while still

With the federal government dramatically altering its guidance on childhood immunizations, the landscape of pediatric care has been thrown into uncertainty. We sat down with a leading expert in public health and infectious disease to unpack what this shift means for parents, doctors, and the health

A high-stakes convergence of science and policy recently unfolded in Doylestown, Bucks County, as National Institutes of Health (NIH) Director Dr. Jay Bhattacharya accepted an invitation from Congressman Brian Fitzpatrick (PA-1) for a firsthand look at a thriving hub of biomedical innovation. The

After a period of cautious investor sentiment that chilled the life sciences sector, Aktis Oncology is making a decisive move into the public domain with an initial public offering that could signal a significant turning point for the industry. The company, a specialist in targeted

Health authorities have issued urgent warnings as the highly contagious measles virus continues its resurgence, with notable outbreaks reminding communities of the persistent threat posed by vaccine-preventable diseases. The ease of modern travel has transformed localized clusters into